Logo image
Back
Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study
Journal article   Peer reviewed

Reactive thrombocytosis and risk of subsequent venous thromboembolism: a cohort study

K.M. Ho, C.B. Yip and O. Duff
Journal of Thrombosis and Haemostasis, Vol.10(9), pp.1768-1774
2012
DOI: https://doi.org/10.1111/j.1538-7836.2012.04846.x
url
Free to Read *No subscription requiredView

Abstract

Background: It is uncertain whether reactive thrombocytosis is associated with an increased risk of venous thromboembolism. This study assessed the incidence of reactive thrombocytosis, defined as platelet count≥500×109L-1, at intensive care unit discharge and its association with subsequent venous thromboembolism. Methods and Results: This cohort study involved linkage of routinely collected intensive care unit, laboratory, radiology and death registry data of critically ill patients admitted to the intensive care unit between January 2009 and March 2010. The census date for survival and radiologically confirmed venous thromboembolism was 31 October 2011. Of the 1446 patients who survived to intensive care unit discharge, 139 patients had reactive thrombocytosis (9.6%, 95% confidence interval [CI] 8.2-11.2%). Twenty-nine patients developed venous thromboembolism after discharge (2%, 95% CI 1.4-2.9%; 67 per 100 person-years, 95% CI 45-97) and the median time to develop venous thromboembolism was 25days (interquartile range 8-148). Reactive thrombocytosis was associated with an increased risk of subsequent venous thromboembolism (hazard ratio 5.3, 95% CI 1.7-16.4), after adjusting for other covariates. Platelet counts explained about 34% of the variability in the risk of venous thromboembolism and had a relatively linear relationship with the risk of venous thromboembolism when the platelet counts were >400×109L-1. Venous thromboembolism after intensive care unit discharge was associated with an increased risk of mortality (hazard ratio 2.0, 95% CI 1.1-3.9), after adjusting for reactive thrombocytosis. Conclusions: Reactive thrombocytosis during the recovery phase of critical illness was associated with an increased risk of subsequent venous thromboembolism.

Details

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Metrics

51 Record Views
54 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
Citation topics
1 Clinical & Life Sciences
1.75 Blood Clotting
1.75.271 Venous Thromboembolism
Web Of Science research areas
Hematology
Peripheral Vascular Disease
ESI research areas
Clinical Medicine
Logo image